DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* MABLIFE *


 

2000 - IDF
Évry
(near Paris)
http://www.mablife.com

 

Discovery, Drugs
Key words: MABs, Antibody-based therapeutics, Cancer, Immuno-therapy, Angiogenesis
Mission: to develop proprietary antibody-based therapeutics for the treatment of cancer
Clients: Pharmaceutical industry (own development up to phase II included)
contact@mablife.com

Age: 17 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Vallet (François) [born 1958, Polytechnique, Ph.D. physics, ex-Genewave (co-founder)]
Sc.Dir.-CSO: Boumsell (Laurence)
Fin.Dir.-CFO: vacant
BusDev: vacant
Financers (Hist.): Génopole 1er Jour, IxCore, Anvar
Notes : full company legal name is Monoclonal Antibodies Therapeutics, up to 2011 ; previous URL was www.matbiopharma.fr ;

Turnover (M€) : 0.05 (2004)
Total funding (M€) : 5.8
Last funding (M€) : 5.8
Focus : Cancers
Position : Clinical
Company confirm : none

 

History
DATEMILESTONETYPETIME
2011 .07 Launch of MAB-Solut new departement, specialised in full spectrum solutions for companies and research labs for antibodies MKTG [11 years]
2011 .07 Company rename as MABlife (from MAT Biopharma) with no change in capital structure, and with the same management ORGL [11 years]
2009 .01 Nomination : François Vallet, as CEO ORGN [8 years]
2008 .09 Clinical trial (phase II) for Ferritarq (completed) CLIN [8 years]
2006 .09 Registration : orphan Drug designation by EMEA for Ferritarq MKTG [6 years]
2006 .02 Partnering research agreement with Pierre Fabre, on anticancer MABs R&D [6 years]
2005 .01 Partnering research agreement with Servier, on anticancer MABs R&D [4 years]
2002 .11 Round-financing : 1.25 M€, by undisclosed investors RFIN [2 years]
2000 .02 Company founded by Dr Jean Kadouche [born 1945, initial CEO], Raphaël Lévy [M.D., Laennec], Bernard Montanari (initially named Monoclonal Antibodies Therapeutics) ORGF [0 year]

Actualisation / Updating: 18-Nov-2012

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende